U.S. Commerce Department Provides Application Process for Onshoring Agreements to Avoid 100% Tariffs on Pharmaceuticals

A notice from the Industry and Security Bureau of the U.S. Department of Commerce was recently published in the Federal Register concerning the Procedures to Apply for Company-Specific Onshoring Agreements to Obtain Tariff Adjustments for Pharmaceuticals and Pharmaceutical Ingredients Under Proclamation 11020. Under the previously issued Proclamation 11020 of 2 April 2026, the U.S. government implemented a 100% tariff on certain imported patented pharmaceuticals and their ingredients (excep…